KRONOS BIO INC. - COM
0.8850
08-10月-24 13:56:50
15 分の遅延
株式
-0.1050
-10.61%
本日の幅
0.8520 - 0.9800
ISIN
N/A
ソース
NASDAQ
-
Kronos Bio Announces Participation in H.C. Wainwright 24th Annual Global Investment Conference
06 9 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
22 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
16 8 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Second-Quarter 2022 Financial Results
04 8 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
10 6 2022 03:04:36 提供 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
01 6 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in H.C. Wainwright Global Investment Conference
17 5 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
12 5 2022 10:23:18 提供 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and First-Quarter 2022 Financial Results
04 5 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
08 3 2022 17:08:22 提供 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Cowen 42nd Annual Health Care Conference
01 3 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results
24 2 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Kronos Bio Announces Appointment of Elizabeth Olek as Senior Vice President of Clinical Development
01 2 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
06 12 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Kronos Bio Announces Positive Data from Ongoing Phase 1/2 Trial of Oral CDK9 Inhibitor KB-0742
29 11 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
24 11 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Kronos Bio Appoints Roshawn Blunt to Board of Directors
11 11 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Third-Quarter Financial Results
09 11 2021 16:10:42 提供 Nasdaq GlobeNewswire